Authors :
Dr. P Kishore Kumar; Thokala Ruchitha; Pasumala Varun; Chinta Rohit Kumar; Dr. T Rama Rao
Volume/Issue :
Volume 10 - 2025, Issue 6 - June
Google Scholar :
https://tinyurl.com/3sdyx3zu
DOI :
https://doi.org/10.38124/ijisrt/25jun1084
Note : A published paper may take 4-5 working days from the publication date to appear in PlumX Metrics, Semantic Scholar, and ResearchGate.
Abstract :
A rare chronic granulomatous vasculitis, Takayasu arteritis (TA) mainly affects big arteries including the aorta
and its major branches. Although autoimmune pathways are strongly implicated, the precise etiology of this condition,
which is most commonly observed in young Asian women, is yet unknown. The illness develops gradually, starting with
vague constitutional symptoms and ending with vascular problems like ischemia, aneurysms, hypertension, and
pulselessness. Clinical examination, laboratory indicators of inflammation, and sophisticated imaging methods like CT
angiography and MRI are all part of the diagnostic evaluation process. Corticosteroids, immunosuppressive medications,
and biologics are commonly used in treatment; in more severe cases, revascularization may be required. Early
identification and specialized multidisciplinary management are crucial because of its systemic nature and its
consequences. With an emphasis on recent developments and treatment concerns, this review offers an updated synopsis
of Takayasu arteritis's categorization, pathogenesis, clinical characteristics, diagnostic standards, and therapy approaches.
Keywords :
Takayasu Arteritis, Large-Vessel Vasculitis, Aortic Inflammation, Pulseless Disease, Angiographic Classification, Autoimmune Vasculitis, Corticosteroids, Biologic Therapy, Vascular Stenosis, Imaging in Vasculitis.
References :
- Trinidad B, Surmachevska N, Lala V. Takayasu Arteritis. [Updated 2023 Aug 8]. In: StatPearls [Internet]. Treasure Island (FL): StatPearls Publishing; 2025 Jan-. Available from: https://www.ncbi.nlm.nih.gov/books/NBK459127/
- Moriwaki R, Noda M, Yajima M, et al. Clinical manifestations of Takayasu arteritis in India and Japan—new classification of angiographic findings. Angiology 1997;48:369–79.
- Ishikawa K. Natural history and classification of occlusive thromboaortopathy (Takayasu's disease). Circulation 1978;57:27–35
- Gravanis MB. Giant cell arteritis and Takayasu aortitis morphologic pathogenetic and etiologic factors. Int J Cardiol. 2000; 75: S21–33.
- Natraj Setty HS, Vijaykumar JR, Nagesh CM, Patil SS, Jadav S, Raghu TR, Manjunath CN. J Rare Dis Res Treat. (2017) 2(2): 63-68
- Kumar V, Abbas AK, Fausto N. Robbins and Cotran pathologic basis of disease. 7thed. New Delhi: Thomson Press; 2007.
- Joseph G, Goel R, Thomson VS, Joseph E, Danda D. Takayasu arteritis: JACC focus seminar 3/4. Journal of the American College of Cardiology. 2023 Jan 17;81(2):172-86.
- “Takayasu's arteritis-Takayasu's arteritis - Symptoms & causes.” Mayo Clinic, https://www.mayoclinic.org/diseases-conditions/takayasus-arteritis/symptoms-causes/syc-20351335. Accessed 16 June 2025.
- Onen F, Akkoc N. Epidemiology of Takayasu arteritis. La Presse Médicale. 2017 Jul 1;46(7-8):e197-203.
- Surmachevska N, Lala V. Takayasu Arteritis. [Updated 2023 Aug 8]. In: StatPearls [Internet]. Treasure Island (FL): StatPearls Publishing; 2025 Jan-. Available from: https://www.ncbi.nlm.nih.gov/books/NBK459127/
- Johnston SL, Lock RJ, Gompels MM. Takayasu arteritis: a review. J Clin Pathol. 2002 Jul;55(7):481-6. doi: 10.1136/jcp.55.7.481. PMID: 12101189; PMCID: PMC1769710.
- Sigl M, Hsu E, Scheffel H, Haneder S, Rümenapf G, Amendt K. Lower extremity vasculitis in giant cell arteritis: important differential diagnosis in patients with lower limb claudication. Vasa. 2014 Sep;43(5):326-36. doi: 10.1024/0301-1526/a000370. PMID: 25147009.
- O'Connor TE, Carpenter HE, Bidari S, Waters MF, Hedna VS. Role of inflammatory markers in Takayasu arteritis disease monitoring. BMC Neurol. 2014 Mar 28;14:62. doi: 10.1186/1471-2377-14-62. PMID: 24678735; PMCID: PMC4012521.
- Zhu FP, Luo S, Wang ZJ, Jin ZY, Zhang LJ, Lu GM. Takayasu arteritis: imaging spectrum at multidetector CT angiography. Br J Radiol. 2012 Dec;85(1020):e1282-92. doi: 10.1259/bjr/25536451. PMID: 23175494; PMCID: PMC3611735.
- Matsunaga N, Hayashi K, Sakamoto I, Ogawa Y, Matsumoto T. Takayasu arteritis: protean radiologic manifestations and diagnosis. Radiographics. 1997 May;17(3):579-94.
- Gaillard F, Weerakkody Y, Sharma R, et al. Takayasu arteritis. Reference article, Radiopaedia.org (Accessed on 16 Jun 2025) https://doi.org/10.53347/rID-2143
- Roberts, Jefferson R., and Herbert S. Diamond. “Takayasu Arteritis: Practice Essentials, Background, Pathophysiology.” Medscape Reference, 29 October 2024, https://emedicine.medscape.com/article/332378-overview. Accessed 16 June 2025.
- Sueyoshi E, Sakamoto I, Uetani M. MRI of Takayasu's arteritis: typical appearances and complications. American journal of roentgenology. 2006 Dec;187(6):W569-75.
- Sharma BK, Jain S, Suri S, Numano F. Diagnostic criteria for Takayasu arteritis. International journal of cardiology. 1996 Aug 1;54:S127-33.
- Parakh R, Yadav A. Takayasu's arteritis: an Indian perspective. European Journal of Vascular and Endovascular Surgery. 2007 May 1;33(5):578-82.
- de Souza AW, de Carvalho JF. Diagnostic and classification criteria of Takayasu arteritis. Journal of autoimmunity. 2014 Feb 1;48:79-83.
- Grayson PC, Ponte C, Suppiah R, Robson JC, Gribbons KB, Judge A, Craven A, Khalid S, Hutchings A, Danda D, Luqmani RA. 2022 American College of Rheumatology/EULAR classification criteria for Takayasu arteritis. Arthritis & Rheumatology. 2022 Dec;74(12):1872-80.
- Bhandari S, Butt SRR, Ishfaq A, Attaallah MH, Ekhator C, Halappa Nagaraj R, Mulmi A, Kamran M, Karski A, Vargas KI, Lazarevic S, Zaman MU, Lakshmipriya Vetrivendan G, Shahzed SMI, Das A, Yadav V, Bellegarde SB, Ullah A. Pathophysiology, Diagnosis, and Management of Takayasu Arteritis: A Review of Current Advances. Cureus. 2023 Jul 29;15(7):e42667. doi: 10.7759/cureus.42667. PMID: 37525862; PMCID: PMC10386905.
- Saadoun, D., Bura-Riviere, A., Comarmond, C. et al. French recommendations for the management of Takayasu’s arteritis. Orphanet J Rare Dis 16 (Suppl 3), 311 (2021). https://doi.org/10.1186/s13023-021-01922-1
- Gokhan Keser, Haner Direskeneli, Kenan Aksu, Management of Takayasu arteritis: a systematic review, Rheumatology, Volume 53, Issue 5, May 2014, Pages 793–801, https://doi.org/10.1093/rheumatology/ket320
A rare chronic granulomatous vasculitis, Takayasu arteritis (TA) mainly affects big arteries including the aorta
and its major branches. Although autoimmune pathways are strongly implicated, the precise etiology of this condition,
which is most commonly observed in young Asian women, is yet unknown. The illness develops gradually, starting with
vague constitutional symptoms and ending with vascular problems like ischemia, aneurysms, hypertension, and
pulselessness. Clinical examination, laboratory indicators of inflammation, and sophisticated imaging methods like CT
angiography and MRI are all part of the diagnostic evaluation process. Corticosteroids, immunosuppressive medications,
and biologics are commonly used in treatment; in more severe cases, revascularization may be required. Early
identification and specialized multidisciplinary management are crucial because of its systemic nature and its
consequences. With an emphasis on recent developments and treatment concerns, this review offers an updated synopsis
of Takayasu arteritis's categorization, pathogenesis, clinical characteristics, diagnostic standards, and therapy approaches.
Keywords :
Takayasu Arteritis, Large-Vessel Vasculitis, Aortic Inflammation, Pulseless Disease, Angiographic Classification, Autoimmune Vasculitis, Corticosteroids, Biologic Therapy, Vascular Stenosis, Imaging in Vasculitis.